Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opioid receptors: drivers to addiction?
Emmanuel Darcq, Brigitte L. Kieffer
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 499-514
Closed Access | Times Cited: 302

Showing 1-25 of 302 citing articles:

Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 248
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder
Hang Zhou, Christopher T. Rentsch, Zhongshan Cheng, et al.
JAMA Psychiatry (2020) Vol. 77, Iss. 10, pp. 1072-1072
Open Access | Times Cited: 163
Amygdala, neuropeptides, and chronic pain-related affective behaviors
Volker Neugebauer, Mariacristina Mazzitelli, Bryce Cragg, et al.
Neuropharmacology (2020) Vol. 170, pp. 108052-108052
Open Access | Times Cited: 144
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Alok Kumar Paul, Craig M. Smith, Mohammed Rahmatullah, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1091-1091
Open Access | Times Cited: 142
Decoding molecular and cellular heterogeneity of mouse nucleus accumbens
Renchao Chen, Timothy R. Blosser, Mohamed Nadhir Djekidel, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 12, pp. 1757-1771
Open Access | Times Cited: 139
Structures of the entire human opioid receptor family
Yue Wang, Youwen Zhuang, Jeffrey F. DiBerto, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 413-427.e17
Open Access | Times Cited: 102
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 51
Opioid Receptors in Immune and Glial Cells—Implications for Pain Control
Halina Machelska, Melih Ö. Celik
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 136
Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders
Hugo A. Tejeda, Antonello Bonci
Brain Research (2018) Vol. 1713, pp. 91-101
Closed Access | Times Cited: 101
The role of stress in drug addiction. An integrative review
Pablo Ruisoto, Israel Contador
Physiology & Behavior (2019) Vol. 202, pp. 62-68
Open Access | Times Cited: 96
The Opioid Crisis and the Future of Addiction and Pain Therapeutics
Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 396-408
Open Access | Times Cited: 88
β-Arrestin Based Receptor Signaling Paradigms: Potential Therapeutic Targets for Complex Age-Related Disorders
Jaana van Gastel, Jhana O. Hendrickx, Hanne Leysen, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 86
Key transcription factors mediating cocaine-induced plasticity in the nucleus accumbens
Collin D. Teague, Eric J. Nestler
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 687-709
Open Access | Times Cited: 66
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 44
Endogenous opioid systems alterations in pain and opioid use disorder
Jessica A. Higginbotham, Tamara Markovic, Nicolas Massaly, et al.
Frontiers in Systems Neuroscience (2022) Vol. 16
Open Access | Times Cited: 41
Mechanisms of opioid-induced respiratory depression
Brian A. Baldo, Michael Rose
Archives of Toxicology (2022) Vol. 96, Iss. 8, pp. 2247-2260
Closed Access | Times Cited: 38
Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement
Fabrice Chaudun, Laurena Python, Yu Liu, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 141-148
Open Access | Times Cited: 14
Peptide–Drug Conjugates: An Emerging Direction for the Next Generation of Peptide Therapeutics
Trevor T. Dean, Juliet Jelú-Reyes, A’Lester C. Allen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1641-1661
Closed Access | Times Cited: 13
The Potential of Cannabichromene (CBC) as a Therapeutic Agent
Diana E. Sepúlveda, Kent E. Vrana, Joshua J. Kellogg, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 206-213
Open Access | Times Cited: 9
The resting-state brain activity signatures for addictive disorders
Hui Zheng, Tianye Zhai, Xiao Lin, et al.
Med (2024) Vol. 5, Iss. 3, pp. 201-223.e6
Open Access | Times Cited: 8
The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models
Lola Welsch, Julie Bailly, Emmanuel Darcq, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 54-63
Open Access | Times Cited: 66
Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system
Emilia M. Lefevre, Marc T. Pisansky, Carlee Toddes, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1781-1792
Open Access | Times Cited: 64
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Samuel D. Clark, Anissa Abi‐Dargham
Biological Psychiatry (2019) Vol. 86, Iss. 7, pp. 502-511
Open Access | Times Cited: 60
Mu opioid receptors in the medial habenula contribute to naloxone aversion
Laura‐Joy Boulos, Sami Ben Hamida, Julie Bailly, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 2, pp. 247-255
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top